Sinopharm's subsidiary CNBG was one of the earliest coronavirus vaccine developers to push for human trials and the world’s first to enter the final stage of trials. Photo: AP Sinopharm's subsidiary CNBG was one of the earliest coronavirus vaccine developers to push for human trials and the world’s first to enter the final stage of trials. Photo: AP
Sinopharm's subsidiary CNBG was one of the earliest coronavirus vaccine developers to push for human trials and the world’s first to enter the final stage of trials. Photo: AP

Coronavirus: Sinopharm applies for regulatory approval from China to launch vaccine, state media reports

  • Chinese pharmaceutical giant files for regulatory approval, according to Xinhua Finance
  • China National Biotec Group executive says data review is not complete but Sinopharm chairman says vaccines are protective and safe

Topic |   Coronavirus pandemic
Sinopharm's subsidiary CNBG was one of the earliest coronavirus vaccine developers to push for human trials and the world’s first to enter the final stage of trials. Photo: AP Sinopharm's subsidiary CNBG was one of the earliest coronavirus vaccine developers to push for human trials and the world’s first to enter the final stage of trials. Photo: AP
Sinopharm's subsidiary CNBG was one of the earliest coronavirus vaccine developers to push for human trials and the world’s first to enter the final stage of trials. Photo: AP
READ FULL ARTICLE